The Central Drug and Standard Control Organization through circular dated 1st September, 2021 has directed manufacturers of FDC drug to market the drug only for symptomatic treatment of post stroke spasticity associated with pain in adults.
Manufacturers of FDC drugs shall also submit Phase IV clinical trail protocol on revised indication.
The ANI stakeholders are Points of Presence (Bank and Non-Bank), Central Record Keeping Agencies, Trustee Banks, Custodians, Aggregators, Annuity Service Providers, Pension Agents, Retirement Advisors,
e-NAM is a demand-driven scheme. The integration of mandis under the e-NAM platform is based on proposals received from State Governments/Union Territories, reflecting their demand
Based on the comments and counter-comments received from stakeholders in the consultation process, and on its own analysis, TRAI has finalized the Recommendations on Assignment
The Government of India launched the IndiaAI Mission on March 7th, 2024, to bolster India’s global leadership in AI and democratize the benefits of AI
Stay up-to-date with the latest regulatory developments from Legality Alerts, directly in your inbox. Never miss another important regulatory compliance news alert.
Solutions
Resources
